Deana Camisa, Senior Administrative Assistant, Johnson & Johnson Health Care Services, has faced ups and downs managing her type 2 diabetes. After nearly 20, years she needed insulin injections and felt discouraged that her efforts to get healthy just weren’t working. But an opportunity to take part in the Live For Life™ pilot program offered at the onsite gym at Janssen, and a chance to be treated with INVOKANA® (canagliflozin), a new medicine for type 2 diabetes, gave Deana renewed hope for better health. This is Deana’s story.
From the 2013 Johnson & Johnson Annual Report